Fundz

Intra Bio Inc reported raising $4.91 Million in an initial SEC Form D filing, from an offering of $10 Million

RECENTLY ACQUIREDAug 20, 2018$4.9M of $10M raised

Amount Raised

$4.91 Million

$4.91 Million sold, per SEC Form D (first sale Aug 20, 2018)

Round Type

Seed

AustinBiotechnology

Quick answer

IntraBio Inc raised $4.91 Million in a Seed round, dated August 20, 2018. IntraBio Inc is based in Austin, Texas, United States.

How much did IntraBio Inc raise?
IntraBio Inc raised $4.91 Million in a Seed round on August 20, 2018.
What does IntraBio Inc do?
IntraBio Inc is a private pharmaceutical company located in London, United Kingdom, focusing on drug development and commercialization related to common and rare neurodegenerative diseases, as well as ageing and..
Where is IntraBio Inc based and how big is it?
IntraBio Inc is based in Austin, Texas, United States. Fundz records about 11 employees.
Who are the decision-makers at IntraBio Inc?
Fundz holds 1 contact at IntraBio Inc, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as IntraBio Inc that raised within 45 days of this round, from Fundz verified event records.

  • Keriton raised $500K (Seed) on October 4, 2018.
  • Spyryx Biosciences, Inc. raised $5.9M on October 4, 2018.
  • Biocartis Group NV raised $138K (Pre-Seed) on October 4, 2018.
  • X-Vax Technology, Inc. raised $6.5M on October 3, 2018.
  • White River Energy raised $100K (Seed) on October 3, 2018.
  • NanoView Biosciences, Inc. raised $9M on October 3, 2018.

Who to call at IntraBio Inc, and when

A new round usually means IntraBio Inc is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day IntraBio Inc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at IntraBio Inc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at IntraBio Inc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

IntraBio Inc

Location

201 W 5th Street, Suite 1100

Austin, Texas, United States

About

IntraBio Inc is a private pharmaceutical company located in London, United Kingdom, focusing on drug development and commercialization related to common and rare neurodegenerative diseases, as well as ageing and healthspan.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment IntraBio Inc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMallory F., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for IntraBio Inc's next move

See what Strategic adds

IntraBio Inc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.